Dabrafenib (C007B-113941)

Dabrafenib (GSK2118436) is a mutant BRAFV600 specific inhibitor with IC50 of 0.8 nM in cell-free assays, with 4- and 6-fold less potency against B-Raf(wt) and c-Raf, respectively.A potent and selective inhibitor of Raf-B protein kinase carrying V600E mutation. Specification: ≥98% Molecular Formula: C23H20F3N5O2S2 Molecular Weight: 519.56 PubChem CID: 44462760 Isomeric SMILES: CC(C)(C)C1=NC(=C(S1)C2=NC(=NC=C2)N)C3=C(C(=CC=C3)NS(=O)(=O)C4=C(C=CC=C4F)F)F Related Documents: https://ald-pub-files.oss-cn-shanghai.aliyuncs.com/aladdinsci/pdp/sds/1/D127289-SCI_14a778b086957f8339ea9a4d910481b0.pdf

UPC:

51343601

Condition:

New

Weight:

1.02 Ounces

HazmatClass:

No

Quantity:

1

Unit of Measurement:

EA

WeightUOM:

LB

MPN:

D127289-1g

CAS:

1195765-45-7

Product Size:

1g

Hazard Statement Codes:

H361:H373:H400:H411

Precautionary Statement Codes:

P260:P273:P280:P391:P405:P501